Publication | Closed Access
Costimulation via CD55 on Human CD4+ T Cells Mediated by CD97
116
Citations
34
References
2006
Year
InflammationComplement SystemCell TherapyAutoimmune DiseaseAllergyDecay-accelerating FactorCross-linking MabsImmunologyImmune RegulationT-regulatory CellImmunologic MechanismAutoimmunityCellular Immune ResponseImmunotherapyMedicineCell BiologyCell SignalingCd3 Results
Decay-accelerating factor (CD55) is a complement regulatory protein, which is expressed by most cells to protect them from complement-mediated attack. CD55 also binds CD97, an EGF-TM7 receptor constitutively expressed on granulocytes and monocytes and rapidly up-regulated on T and B cells upon activation. Early results suggested that CD55 could further enhance T cell proliferation induced by phorbol ester treatment. The present study demonstrates that coengagement of CD55, using either cross-linking mAbs or its natural ligand CD97, and CD3 results in enhanced proliferation of human peripheral blood CD4(+) T cells, expression of the activation markers CD69 and CD25, and secretion of IL-10 and GM-CSF. Recently, an increase in T cell responsiveness in CD55(-/-) mice was shown to be mediated by a lack of complement regulation. In this study, we show that direct stimulation of CD55 on CD4(+) T cells with CD97 can modulate T cell activation but does not interfere with CD55-mediated complement regulation. Our results support a multifaceted role for CD55 in human T cell activation, constituting a further link between innate and adaptive immunity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1